Alaunos Therapeutics TCRT
NASDAQ TCRT
$0.82 -0.08 (-8.89%)
At close: Oct 2, 2026 · 4:00 PM EDT

Alaunos Therapeutics (TCRT) Cash & Current Investments (2009 - 2026)

Updated

Alaunos Therapeutics (TCRT) posted Cash & Current Investments of $124,000 for Q2 2026, down 95.7% from $2.88 million a year earlier and down 65.0% from the prior quarter.

Analysis

Alaunos Therapeutics (TCRT) Cash & Current Investments (2009 - 2026) Analysis & Trends

At the end of FY2025, Alaunos Therapeutics' Cash & Current Investments came in at $1.39 million, up 26.9% from FY2024.

  • Annual Cash & Current Investments shows a five-year compound annual growth rate of -58.7% (FY2020 to FY2025).
  • In prior years, Alaunos Therapeutics' Cash & Current Investments was $1.09 million in FY2024 (-82.0%), $6.06 million in FY2023 (-84.5%), $39.06 million in FY2022 (-48.6%) and $76.05 million in FY2021 (-33.9%).
  • The Q2 2026 figure stands as the lowest quarterly Cash & Current Investments in data going back to Q3 2009.
  • On a year-over-year basis, Cash & Current Investments increased in four of the last eight quarters, with an average decline of 35.7%.
  • The strongest year-over-year quarter for Cash & Current Investments in the past five years was Q4 2025, with growth of 26.9%; the weakest was Q2 2026, with a decline of 95.7%.
  • According to Business Quant data, Cash & Current Investments for the three prior quarters was $354,000 (Q1 2026), $1.39 million (Q4 2025) and $1.94 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 20.76 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 6.57 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 9.92 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 4.97 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 3.18 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.70 Bn
10 Alaunos Therapeutics 2.04 Mn -1.76 Mn - 124,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 124,000.00
Mar 31, 2026 354,000.00
Dec 31, 2025 1.39 Mn
Sep 30, 2025 1.94 Mn
Jun 30, 2025 2.88 Mn
Mar 31, 2025 319,000.00
Dec 31, 2024 1.09 Mn
Sep 30, 2024 1.68 Mn
Jun 30, 2024 2.46 Mn
Mar 31, 2024 4.15 Mn
Dec 31, 2023 6.06 Mn
Sep 30, 2023 11.94 Mn
Jun 30, 2023 18.32 Mn
Mar 31, 2023 23.50 Mn
Dec 31, 2022 39.06 Mn
Sep 30, 2022 37.81 Mn
Jun 30, 2022 60.01 Mn
Mar 31, 2022 68.30 Mn
Dec 31, 2021 76.05 Mn
Sep 30, 2021 91.73 Mn
API Access

Alaunos Therapeutics Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=TCRT&period=max&api_key=YOUR_API_KEY